Skye Bioscience, Inc. - COM NEW (SKYE)

Historical Portfolio Holders from Q4 2023 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q3 2024
25.7M
Holdings value Q3 2024
$101M
Value change Q3 2024
+$1.21M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
70
Number of buys Q3 2024
35
Number of sells Q3 2024
-18
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 25.7M $101M +$1.21M $3.91 71
2024 Q2 24.5M $196M +$180M $8.01 62
2024 Q1 2.01M $31.4M +$31.4M $15.64 3
2023 Q4 1.6K $4.35K $0 $2.72 1